Blood cancers

Haematologic malignancies associated with higher COVID-19 mortality rates

More than one quarter of patients with haematologic malignancies who contract a COVID-19 infection die, according to global data presented at the ASH 2020 Annual Meeting. “Haematologic diseases often induce underlying immune dysregulation or dysfunction,” said Dr William Wood, of the University of North Carolina, who presented the new results. “Patients with haematologic malignancies are ...

Already a member?

Login to keep reading.

© 2021 the limbic